S0Z0 Stock Overview
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Sientra, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.053 |
| 52 Week High | US$4.04 |
| 52 Week Low | US$0.053 |
| Beta | 2.03 |
| 1 Month Change | -90.45% |
| 3 Month Change | -92.91% |
| 1 Year Change | -96.30% |
| 3 Year Change | -99.91% |
| 5 Year Change | -99.94% |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| S0Z0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -62.8% | -1.9% | -1.0% |
| 1Y | -96.3% | -10.8% | 2.0% |
Return vs Industry: S0Z0 underperformed the German Medical Equipment industry which returned 5% over the past year.
Return vs Market: S0Z0 underperformed the German Market which returned 1% over the past year.
Price Volatility
| S0Z0 volatility | |
|---|---|
| S0Z0 Average Weekly Movement | 61.5% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: S0Z0's share price has been volatile over the past 3 months.
Volatility Over Time: S0Z0's weekly volatility has increased from 36% to 61% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 304 | Ron Menezes | sientra.com |
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers.
Sientra, Inc. Fundamentals Summary
| S0Z0 fundamental statistics | |
|---|---|
| Market cap | €991.50k |
| Earnings (TTM) | -€54.66m |
| Revenue (TTM) | €83.19m |
0.0x
P/S Ratio0.0x
P/E RatioIs S0Z0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S0Z0 income statement (TTM) | |
|---|---|
| Revenue | US$90.30m |
| Cost of Revenue | US$52.28m |
| Gross Profit | US$38.02m |
| Other Expenses | US$97.35m |
| Earnings | -US$59.33m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.96 |
| Gross Margin | 42.11% |
| Net Profit Margin | -65.71% |
| Debt/Equity Ratio | -183.5% |
How did S0Z0 perform over the long term?
See historical performance and comparison